cas 6639-87-8|| where to buy 6-nitroquinoxaline

Nom du produit:6-nitroquinoxaline

IUPAC Name:6-nitroquinoxaline

: CAS：6639-87-8; Formule moléculaire：C8H5N3O2; Pureté：95%

: Numéro de catalogue：CM100001; Poids moléculaire：175.15

Unité d'emballage	Stock disponible	Prix($)
CM100001-5g	in stock	ŌǸ
CM100001-10g	in stock	ǎǸŌ
CM100001-25g	in stock	ĳĳǸ

Demande: sales@chemenu.com

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 6639-87-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

Détails du produit

: N° CAS:6639-87-8; Formule moléculaire:C8H5N3O2; Point de fusion:-; Code SMILES:C1=CC2=NC=CN=C2C=C1[N+](=O)[O-]; Densité:1.437g/cm3

: Numéro de catalogue:CM100001; Poids moléculaire:175.15; Point d'ébullition:; N° Mdl:MFCD00462822; Stockage:Store at room temperature.

Category Infos

: Quinoxalines; Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Column Infos

: Quinoxalines

Product Other Information

Synthesis Method

6-Nitroquinoxaline can be synthesized in a two-step process. The first step involves the condensation of o-nitroaniline with ethyl acetoacetate in the presence of an acid catalyst to form the intermediate 2-methyl-6-nitroquinoxaline. This intermediate can then be reduced with sodium borohydride to yield 6-nitroquinoxaline.